Literature DB >> 2443088

Angiostatic steroids. Method of discovery and mechanism of action.

J Folkman, D E Ingber.   

Abstract

A new class of steroids has been found that inhibits angiogenesis in the presence of nonanticoagulant heparin. Tetrahydrocortisol is the most potent of the naturally occurring angiostatic steroids. It is a metabolite of cortisone that circulates in the blood, appears in the urine, and was previously believed to be biologically inactive. Both the plasma form and the urinary form are antiangiogenic. The mechanism of action of these steroids depends on their ability to specifically alter basement membrane turnover in growing capillary blood vessels. These steroids represent a prototype of angiogenesis inhibitors that may find potential therapeutic use as adjuncts to anticancer therapy, and in diseases dominated by abnormal neovascularization, i.e., angiogenesis-dependent diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443088      PMCID: PMC1493178          DOI: 10.1097/00000658-198709000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  A substrate analog inhibitor for arylsulfatase reduces NK cell cytotoxicity.

Authors:  D Zucker-Franklin; Z F Nabi
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

Review 2.  What is the role of endothelial cells in angiogenesis?

Authors:  J Folkman
Journal:  Lab Invest       Date:  1984-12       Impact factor: 5.662

3.  Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages.

Authors:  T K Hunt; D R Knighton; K K Thakral; W H Goodson; W S Andrews
Journal:  Surgery       Date:  1984-07       Impact factor: 3.982

4.  Protamine is an inhibitor of angiogenesis.

Authors:  S Taylor; J Folkman
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

5.  Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium.

Authors:  D S Salomon; L A Liotta; W R Kidwell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.

Authors:  R Crum; S Szabo; J Folkman
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

7.  Changing patterns of fibronectin, laminin, type IV collagen, and a basement membrane proteoglycan during rat Mullerian duct regression.

Authors:  H Ikawa; R L Trelstad; J M Hutson; T F Manganaro; P K Donahoe
Journal:  Dev Biol       Date:  1984-03       Impact factor: 3.582

8.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

9.  Heparin-like molecules as regulators of atherogenesis.

Authors:  R D Rosenberg; L M Fritze; J J Castellot; M J Karnovsky
Journal:  Nouv Rev Fr Hematol       Date:  1984

10.  Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.

Authors:  P J Polverini; S J Leibovich
Journal:  Lab Invest       Date:  1984-12       Impact factor: 5.662

View more
  52 in total

1.  Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.

Authors:  Jeremy M Sivak; Allison C Ostriker; Amber Woolfenden; John Demirs; Rosemarie Cepeda; Debby Long; Karen Anderson; Bruce Jaffee
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

Review 2.  Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Authors:  L Schweigerer; T Fotsis
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

3.  Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  E Rechtman; R P Danis; L M Pratt; A Harris
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

4.  Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids--quantitative measurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry.

Authors:  Ravinder Earla; Sai H S Boddu; Kishore Cholkar; Sudharshan Hariharan; Jwala Jwala; Ashim K Mitra
Journal:  J Pharm Biomed Anal       Date:  2010-01-18       Impact factor: 3.935

5.  Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone.

Authors:  S F Moss; P Ghosh; D M Thomas; J E Jackson; J Calam
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 6.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

7.  Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.

Authors:  D Shweiki; A Itin; G Neufeld; H Gitay-Goren; E Keshet
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  The use of angiostatic steroids to inhibit cartilage destruction in an in vivo model of granuloma-mediated cartilage degradation.

Authors:  P R Colville-Nash; M el-Ghazaly; D A Willoughby
Journal:  Agents Actions       Date:  1993-01

9.  Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.

Authors:  Y Hori; D E Hu; K Yasui; R L Smither; G A Gresham; T P Fan
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.

Authors:  R R Ricketts; R M Hatley; B J Corden; H Sabio; C G Howell
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.